StreetInsider.com News Articles

CONMED's AirSeal cleared for use with Intuitive da Vinci 5 hex cannula

Wed, 22 Jul 2026 07:01:37 -0400

CONMED Corporation (NYSE: CNMD) announced that its AirSeal Robotic Solution has received an expanded FDA indication for use with Intuitive's 8 mm hex cannulas on the da Vinci 5 platform.

The expanded indication adds to the product's existing clearance for use with Intuitive's 8 mm round cannulas. AirSeal Robotic Solution is now indicated for use across Intuitive's da Vinci X, da Vinci Xi, and da Vinci 5 robotic systems.

According to the company, the expanded indication followed engineering and technical compatibility testing conducted by CONMED in collaboration with Intuitive.

"We are pleased to secure and announce this expanded indication for use, which was

CONMED's AirSeal cleared for use with Intuitive da Vinci 5 hex cannula

Wed, 22 Jul 2026 07:01:37 -0400

CONMED Corporation (NYSE: CNMD) announced that its AirSeal Robotic Solution has received an expanded FDA indication for use with Intuitive's 8 mm hex cannulas on the da Vinci 5 platform.

According to the company, the expanded indication followed engineering and technical compatibility testing conducted by CONMED in collaboration with Intuitive.

"We are pleased to secure and announce this expanded indication for use, which was

CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

Wed, 22 Jul 2026 07:00:00 -0400

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform (“dV5”). Alongside its existing indication for Intuitive 8 mm round cannulas, the AirSeal Robotic Solution now has an expanded indication for use across Intuitive’s portfolio of da Vinci X, da Vinci Xi, and da Vinci 5 robotic systems.

Building on the existing indication for Intuitive’s da Vinci 8mm round cannulas, AirSeal Robotic Solution is now also indicated for use

CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

Wed, 22 Jul 2026 07:00:00 -0400

Building on the existing indication for Intuitive’s da Vinci 8mm round cannulas, AirSeal Robotic Solution is now also indicated for use

CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

Wed, 22 Jul 2026 07:00:00 -0400

Building on the existing indication for Intuitive’s da Vinci 8mm round cannulas, AirSeal Robotic Solution is now also indicated for use

CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

Wed, 22 Jul 2026 07:00:00 -0400

Building on the existing indication for Intuitive’s da Vinci 8mm round cannulas, AirSeal Robotic Solution is now also indicated for use

CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

Mon, 20 Jul 2026 07:00:00 -0400

Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal® technology

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL.

During the meeting, Professor Nikhil Vasdev, FRCS (Urol), MCh (Urol), DSc will present data from a prospective randomized controlled clinical trial conducted by Vasdev et al., which investigated differences in the levels of intraoperative and post-operative pain between two abdominal insufflators, CONMED’s AirSeal® Insufflation System and Stryker’s

CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

Mon, 20 Jul 2026 07:00:00 -0400

Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal® technology

CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

Mon, 20 Jul 2026 07:00:00 -0400

Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal® technology

CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

Mon, 20 Jul 2026 07:00:00 -0400

Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal® technology

Form 4 CONMED Corp For: Jul 15 Filed by: Gallagher John E

Fri, 17 Jul 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260717/26783921.html

Form 4 CONMED Corp For: Jul 15 Filed by: Gallagher John E

Fri, 17 Jul 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260717/26783921.html

Form 3 CONMED Corp For: Jul 15 Filed by: Gallagher John E

Fri, 17 Jul 2026 15:06:00 -0400

si-local-file:///var/storage/secattach/20260717/26783908.html

Form 3 CONMED Corp For: Jul 15 Filed by: Gallagher John E

Fri, 17 Jul 2026 15:06:00 -0400

si-local-file:///var/storage/secattach/20260717/26783908.html

Needham Comments on CONMED (CNMD) Amid Sale Rumors

Tue, 14 Jul 2026 05:44:11 -0400

Needham analyst Mike Matson reiterated a Hold rating on CONMED (NYSE: CNMD).

The analyst comments "After the market closed on 7/10/26, Bloomberg reported that CNMD has been exploring a possible sale of the company. We believe that a sale makes sense given CNMD's mid-single digit growth, strong recurring revenue composition, and depressed valuation. We expect a large premium to CNMD's discount valuation prior to the report and we believe that offers could be at a ~30-50% premium to CNMD's recent average share price ~$35 (~$46-53 per share). We think that CNMD could be attractive to larger companies but we believe that

Conmed shares jump on potential sale report

Fri, 10 Jul 2026 16:41:58 -0400

Investing.com -- Shares of CONMED Corporation rose more than 8% in after-hours trading on Friday following a Bloomberg report that the medical device company is exploring a potential sale.

The company is evaluating its options after receiving takeover interest, according to the report.

Conmed weighing sale after takeover interest - Bloomberg

Fri, 10 Jul 2026 16:36:21 -0400

Conmed weighing sale after takeover interest - Bloomberg

Fri, 10 Jul 2026 16:36:21 -0400

Conmed weighing sale after takeover interest - Bloomberg

Fri, 10 Jul 2026 16:36:21 -0400

Conmed weighing sale after takeover interest - Bloomberg

Fri, 10 Jul 2026 16:36:21 -0400

Conmed weighing sale after takeover interest - Bloomberg

BMO Capital Starts CONMED (CNMD) at Market Perform

Wed, 08 Jul 2026 16:28:16 -0400

BMO Capital initiates coverage on CONMED (NYSE: CNMD) with a Market Perform rating.

For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.

Shares of CONMED closed at $34.24 yesterday.

Form 4 CONMED Corp For: Jul 01 Filed by: Martin Celine Christine

Thu, 02 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260702/26729465.html

Form 4 CONMED Corp For: Jul 01 Filed by: Martin Celine Christine

Thu, 02 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260702/26729465.html

Form 4 CONMED Corp For: Jul 01 Filed by: Mirviss Jeffrey B.

Thu, 02 Jul 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260702/26729422.html

Form 4 CONMED Corp For: Jul 01 Filed by: Mirviss Jeffrey B.

Thu, 02 Jul 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260702/26729422.html